Health
Lundquist Institute receives grant to evaluate safety, efficacy of compound for treating psychological distress – News-Medical.Net
The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy…
The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness.
The grant will also support education and outreach programs related to the use of psilocybin within the field of palliative care. This innovative and first-of-its-kind psychedelic study will be conducted…
-
Noosa News20 hours agoSecurity concerns over Chinese-made Yutong fleet dismissed
-
Noosa News20 hours agoEx-Townsville mayor Troy Thompson lied about army service, degrees, and cancer, says CCC
-
Noosa News22 hours agoQueensland’s domestic violence policing and policies are being shaped by lived experience
-
Noosa News24 hours agoProject leader Jessica Paton named Metro Tasmania’s new CEO
